Pharmaceutical Report

Monday, March 12, 2007

Glaxo begins battle for cervical cancer market


Glaxo begins battle for cervical cancer market

CATHERINE BOYLE

The Business

10 Mar 2007



GLAXOSMITHKLINE (GSK), the drugs giant, is to apply for American approval of its cervical cancer vaccine within weeks. Its Cervarix injection would compete head-on with Gardasil, the vaccine developed by Merck in partnership with Sanofi Aventis, which... read more...

Monday, March 05, 2007

Novartis feels heat as row over cheap drugs builds

Novartis feels heat as row over cheap drugs builds

By Jeanne Whalen And Peter Wonacott

The Wall Street Journal Europe

05 Mar 2007



Whencharitablegroupsaccused NovartisAGofjeopardizingthesupply of inexpensive medicine to poor countries late last year, the Swiss drug giant thought it could swiftly win over its critics. Instead, the fight is only gathering momentum, with world... read more...